GlassScriptPhysician profile
Laura Downey
NPI 1215932553
$2,490.06
in general payments reported to CMS, 2019-2025
17 companies · $514 in 2025
The $514 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $115 · 2021: $307 · 2022: $492 · 2023: $605 · 2024: $250 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,237 · Education: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,236.70 |
| Education | $132.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $638.72 | 2019-2025 | |
| Glaxosmithkline, LLC. | $575.72 | 2021-2025 | Nucala |
| Optinose US, INC. | $501.87 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $365.72 | 2019-2025 | Dupixent |
| Sanofi-Aventis U.S. LLC | $98.99 | 2023 | |
| Medtronic, INC. | $45.33 | 2023-2024 | Sinuva |
| Aerin Medical INC. | $37.68 | 2024 | |
| Amgen INC. | $34.00 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.43 | 2024-2025 | Takhzyro |
| Merck Sharp & Dohme LLC | $30.83 | 2021-2023 | Verquvo |
| Stryker Corporation | $27.34 | 2025 | Xpress Loprofile |
| Alk-Abello, INC | $24.84 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $18.27 | 2025 | Tezspire |
| Acclarent, INC | $16.94 | 2020 | |
| Biocryst US Sales Co., LLC | $16.74 | 2024 | Orladeyo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $13.01 | 2019 | |
| Hikma Pharmaceuticals USA | $12.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Downey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.